|
Mikhailova N.A.
Roxadustat: treatment of anemia and additional clinical effects (literature review)
|
№2 / 2024
|
|
Z.G. Akhmedova, T.V. Mekhtiev
Assessment of the risk of developing complications of type 2 diabetes mellitus in the Azerbaijani population using various formulas to calculate the glomerular filtration rate
|
№2 / 2021
|
|
K.A. Aitbaev, I.T. Murkamilov, Zh.A. Murkamilova, V.V. Fomin
Epigenetic regulation of renal fibrosis in diabetic nephropathy: focus on histone modifications
|
№2 / 2018
|
|
М.А. Устинова, М.М. Батюшин
Анализ влияния маркеров почечного повреждения при нарушении углеводного обмена на риск появления неселективной протеинурии
|
№4 / 2017
|
|
N.A. Yarkova, N.N. Borovkov
Urinary biomarker of podotsitarian dysfunction: importance for early diagnosis of kidney damage to type 2 diabetes mellitus
|
№3 / 2017
|
|
M.V. Kaplanyan, V.Yu. Ryasnyanskii, N.V. Vorokhobina
Using different equations for estimating glomerular filtration rate in patients with type 1 diabetes
|
№2 / 2016
|
|
Antioxidants in nephrology: bardoxolone and diabetic nephropathy
|
№3 / 2013
|
|
A.A. Svistunov, V.V. Fomin
Sulodexide and chronic kidney disease: clinical and experimental studies
|
№2 / 2013
|
|
Demicheva T.P.
Diabetic nephropathy and anemia: treatment considerations
|
№5-6 / 2012
|
|
Bondar I.А.,Klimontov V.V., Romanov V.V.
Urinary excretion of matrix metalloproteinases and their inhibitors in type 1 diabetic patients with nephropathy
|
№5-6 / 2012
|
|
G.A. Alexandrovich, E.I. Andreeva, A.S. Markov, N.N. Morozova, G.A. Saneeva, I.A. Unanova
Role of sulodexide in treatment of diabetic nephropathy in patients with type 1 diabetes mellitus
|
№1 / 2012
|
|
N.I. Vilkova
Unresolved questions of diabetic nephropathy (part I)
|
№3 / 2011
|
Русский
